| Andrea Berube, | |
|
1000 4th St Sw, Mason City, IA 50401-2800 | |
| (641) 428-7000 | |
| Not Available |
| Full Name | Andrea Berube |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 9 Years |
| Location | 1000 4th St Sw, Mason City, Iowa |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205223989 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercyone North Iowa Medical Center | Mason city, IA | Hospital |
| Buffalo Hospital | Buffalo, MN | Hospital |
| Healtheast St John's Hospital | Maplewood, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Allina Health System | 4587573613 | 3071 |
| Metropolitan Anesthesia Network Llp | 5698689123 | 647 |
| St Francis Regional Medical Center | 7214821909 | 88 |
| North Iowa Mercy Clinics | 7810809076 | 242 |
News Archive
Governors nationwide are taking a scalpel to Medicaid, the jointly run state and federal health-care program for 48 million poor Americans, half of whom are children. The single biggest expense for states, Medicaid consumes about 22 percent of their total $1.6 trillion in expenditures, more than what is allocated to elementary and secondary education, according to a National Governors Association report.
An international team of researchers from the United States and Australia, including researchers at Moffitt Cancer Center in Tampa, Fla., have found that the oral BRAF inhibitor vemurafenib (PLX4032) when tested in a phase II clinical trial offered a high rate of response in patients with previously treated metastatic melanoma and who had the BRAF mutation.
Results from the first multi-center pilot study of deep brain stimulation (DBS) for major depressive disorder were published online today by the Journal of Neurosurgery. The study, conducted at three research facilities in Canada, was designed to replicate and build upon an earlier study by Dr. Andres Lozano and Dr. Helen Mayberg which was published in the journal Neuron in 2005.
Dr. Chris Berger, CMB Interim Director and Director of Graduate Education for the College of Medicine, announced the winner of the 2014 Norman R. Alpert Award at the annual Graduate Research Day for the CMB Program event held October 2, 2014. Jacqueline Leung, a graduate student in the Cellular, Molecular and Biosciences (CMB) Program at the University of Vermont won for her publication, "Identification of T. gondii Myosin Light Chain-1 as a Direct Target of TachypleginA-2, a Small-Molecule Inhibitor of Parasite Motility and Invasion."1
› Verified 6 days ago
| Entity Name | Fairview Health Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013994359 PECOS PAC ID: 1951213057 Enrollment ID: O20031105000461 |
News Archive
Governors nationwide are taking a scalpel to Medicaid, the jointly run state and federal health-care program for 48 million poor Americans, half of whom are children. The single biggest expense for states, Medicaid consumes about 22 percent of their total $1.6 trillion in expenditures, more than what is allocated to elementary and secondary education, according to a National Governors Association report.
An international team of researchers from the United States and Australia, including researchers at Moffitt Cancer Center in Tampa, Fla., have found that the oral BRAF inhibitor vemurafenib (PLX4032) when tested in a phase II clinical trial offered a high rate of response in patients with previously treated metastatic melanoma and who had the BRAF mutation.
Results from the first multi-center pilot study of deep brain stimulation (DBS) for major depressive disorder were published online today by the Journal of Neurosurgery. The study, conducted at three research facilities in Canada, was designed to replicate and build upon an earlier study by Dr. Andres Lozano and Dr. Helen Mayberg which was published in the journal Neuron in 2005.
Dr. Chris Berger, CMB Interim Director and Director of Graduate Education for the College of Medicine, announced the winner of the 2014 Norman R. Alpert Award at the annual Graduate Research Day for the CMB Program event held October 2, 2014. Jacqueline Leung, a graduate student in the Cellular, Molecular and Biosciences (CMB) Program at the University of Vermont won for her publication, "Identification of T. gondii Myosin Light Chain-1 as a Direct Target of TachypleginA-2, a Small-Molecule Inhibitor of Parasite Motility and Invasion."1
› Verified 6 days ago
| Entity Name | Metropolitan Anesthesia Network Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558314427 PECOS PAC ID: 5698689123 Enrollment ID: O20031118000579 |
News Archive
Governors nationwide are taking a scalpel to Medicaid, the jointly run state and federal health-care program for 48 million poor Americans, half of whom are children. The single biggest expense for states, Medicaid consumes about 22 percent of their total $1.6 trillion in expenditures, more than what is allocated to elementary and secondary education, according to a National Governors Association report.
An international team of researchers from the United States and Australia, including researchers at Moffitt Cancer Center in Tampa, Fla., have found that the oral BRAF inhibitor vemurafenib (PLX4032) when tested in a phase II clinical trial offered a high rate of response in patients with previously treated metastatic melanoma and who had the BRAF mutation.
Results from the first multi-center pilot study of deep brain stimulation (DBS) for major depressive disorder were published online today by the Journal of Neurosurgery. The study, conducted at three research facilities in Canada, was designed to replicate and build upon an earlier study by Dr. Andres Lozano and Dr. Helen Mayberg which was published in the journal Neuron in 2005.
Dr. Chris Berger, CMB Interim Director and Director of Graduate Education for the College of Medicine, announced the winner of the 2014 Norman R. Alpert Award at the annual Graduate Research Day for the CMB Program event held October 2, 2014. Jacqueline Leung, a graduate student in the Cellular, Molecular and Biosciences (CMB) Program at the University of Vermont won for her publication, "Identification of T. gondii Myosin Light Chain-1 as a Direct Target of TachypleginA-2, a Small-Molecule Inhibitor of Parasite Motility and Invasion."1
› Verified 6 days ago
| Entity Name | American Anesthesiology Of Minnesota Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588669840 PECOS PAC ID: 9335053842 Enrollment ID: O20031118000940 |
News Archive
Governors nationwide are taking a scalpel to Medicaid, the jointly run state and federal health-care program for 48 million poor Americans, half of whom are children. The single biggest expense for states, Medicaid consumes about 22 percent of their total $1.6 trillion in expenditures, more than what is allocated to elementary and secondary education, according to a National Governors Association report.
An international team of researchers from the United States and Australia, including researchers at Moffitt Cancer Center in Tampa, Fla., have found that the oral BRAF inhibitor vemurafenib (PLX4032) when tested in a phase II clinical trial offered a high rate of response in patients with previously treated metastatic melanoma and who had the BRAF mutation.
Results from the first multi-center pilot study of deep brain stimulation (DBS) for major depressive disorder were published online today by the Journal of Neurosurgery. The study, conducted at three research facilities in Canada, was designed to replicate and build upon an earlier study by Dr. Andres Lozano and Dr. Helen Mayberg which was published in the journal Neuron in 2005.
Dr. Chris Berger, CMB Interim Director and Director of Graduate Education for the College of Medicine, announced the winner of the 2014 Norman R. Alpert Award at the annual Graduate Research Day for the CMB Program event held October 2, 2014. Jacqueline Leung, a graduate student in the Cellular, Molecular and Biosciences (CMB) Program at the University of Vermont won for her publication, "Identification of T. gondii Myosin Light Chain-1 as a Direct Target of TachypleginA-2, a Small-Molecule Inhibitor of Parasite Motility and Invasion."1
› Verified 6 days ago
| Entity Name | Saint Elizabeths Hospital Of Wabasha Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659355600 PECOS PAC ID: 5092619387 Enrollment ID: O20031119000811 |
News Archive
Governors nationwide are taking a scalpel to Medicaid, the jointly run state and federal health-care program for 48 million poor Americans, half of whom are children. The single biggest expense for states, Medicaid consumes about 22 percent of their total $1.6 trillion in expenditures, more than what is allocated to elementary and secondary education, according to a National Governors Association report.
An international team of researchers from the United States and Australia, including researchers at Moffitt Cancer Center in Tampa, Fla., have found that the oral BRAF inhibitor vemurafenib (PLX4032) when tested in a phase II clinical trial offered a high rate of response in patients with previously treated metastatic melanoma and who had the BRAF mutation.
Results from the first multi-center pilot study of deep brain stimulation (DBS) for major depressive disorder were published online today by the Journal of Neurosurgery. The study, conducted at three research facilities in Canada, was designed to replicate and build upon an earlier study by Dr. Andres Lozano and Dr. Helen Mayberg which was published in the journal Neuron in 2005.
Dr. Chris Berger, CMB Interim Director and Director of Graduate Education for the College of Medicine, announced the winner of the 2014 Norman R. Alpert Award at the annual Graduate Research Day for the CMB Program event held October 2, 2014. Jacqueline Leung, a graduate student in the Cellular, Molecular and Biosciences (CMB) Program at the University of Vermont won for her publication, "Identification of T. gondii Myosin Light Chain-1 as a Direct Target of TachypleginA-2, a Small-Molecule Inhibitor of Parasite Motility and Invasion."1
› Verified 6 days ago
| Entity Name | Eye Clinic Of Faribault, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831154681 PECOS PAC ID: 9436052677 Enrollment ID: O20040127000937 |
News Archive
Governors nationwide are taking a scalpel to Medicaid, the jointly run state and federal health-care program for 48 million poor Americans, half of whom are children. The single biggest expense for states, Medicaid consumes about 22 percent of their total $1.6 trillion in expenditures, more than what is allocated to elementary and secondary education, according to a National Governors Association report.
An international team of researchers from the United States and Australia, including researchers at Moffitt Cancer Center in Tampa, Fla., have found that the oral BRAF inhibitor vemurafenib (PLX4032) when tested in a phase II clinical trial offered a high rate of response in patients with previously treated metastatic melanoma and who had the BRAF mutation.
Results from the first multi-center pilot study of deep brain stimulation (DBS) for major depressive disorder were published online today by the Journal of Neurosurgery. The study, conducted at three research facilities in Canada, was designed to replicate and build upon an earlier study by Dr. Andres Lozano and Dr. Helen Mayberg which was published in the journal Neuron in 2005.
Dr. Chris Berger, CMB Interim Director and Director of Graduate Education for the College of Medicine, announced the winner of the 2014 Norman R. Alpert Award at the annual Graduate Research Day for the CMB Program event held October 2, 2014. Jacqueline Leung, a graduate student in the Cellular, Molecular and Biosciences (CMB) Program at the University of Vermont won for her publication, "Identification of T. gondii Myosin Light Chain-1 as a Direct Target of TachypleginA-2, a Small-Molecule Inhibitor of Parasite Motility and Invasion."1
› Verified 6 days ago
| Entity Name | St Francis Regional Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447605514 PECOS PAC ID: 7214821909 Enrollment ID: O20040212000408 |
News Archive
Governors nationwide are taking a scalpel to Medicaid, the jointly run state and federal health-care program for 48 million poor Americans, half of whom are children. The single biggest expense for states, Medicaid consumes about 22 percent of their total $1.6 trillion in expenditures, more than what is allocated to elementary and secondary education, according to a National Governors Association report.
An international team of researchers from the United States and Australia, including researchers at Moffitt Cancer Center in Tampa, Fla., have found that the oral BRAF inhibitor vemurafenib (PLX4032) when tested in a phase II clinical trial offered a high rate of response in patients with previously treated metastatic melanoma and who had the BRAF mutation.
Results from the first multi-center pilot study of deep brain stimulation (DBS) for major depressive disorder were published online today by the Journal of Neurosurgery. The study, conducted at three research facilities in Canada, was designed to replicate and build upon an earlier study by Dr. Andres Lozano and Dr. Helen Mayberg which was published in the journal Neuron in 2005.
Dr. Chris Berger, CMB Interim Director and Director of Graduate Education for the College of Medicine, announced the winner of the 2014 Norman R. Alpert Award at the annual Graduate Research Day for the CMB Program event held October 2, 2014. Jacqueline Leung, a graduate student in the Cellular, Molecular and Biosciences (CMB) Program at the University of Vermont won for her publication, "Identification of T. gondii Myosin Light Chain-1 as a Direct Target of TachypleginA-2, a Small-Molecule Inhibitor of Parasite Motility and Invasion."1
› Verified 6 days ago
| Entity Name | Allina Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295272342 PECOS PAC ID: 4587573613 Enrollment ID: O20040319000460 |
News Archive
Governors nationwide are taking a scalpel to Medicaid, the jointly run state and federal health-care program for 48 million poor Americans, half of whom are children. The single biggest expense for states, Medicaid consumes about 22 percent of their total $1.6 trillion in expenditures, more than what is allocated to elementary and secondary education, according to a National Governors Association report.
An international team of researchers from the United States and Australia, including researchers at Moffitt Cancer Center in Tampa, Fla., have found that the oral BRAF inhibitor vemurafenib (PLX4032) when tested in a phase II clinical trial offered a high rate of response in patients with previously treated metastatic melanoma and who had the BRAF mutation.
Results from the first multi-center pilot study of deep brain stimulation (DBS) for major depressive disorder were published online today by the Journal of Neurosurgery. The study, conducted at three research facilities in Canada, was designed to replicate and build upon an earlier study by Dr. Andres Lozano and Dr. Helen Mayberg which was published in the journal Neuron in 2005.
Dr. Chris Berger, CMB Interim Director and Director of Graduate Education for the College of Medicine, announced the winner of the 2014 Norman R. Alpert Award at the annual Graduate Research Day for the CMB Program event held October 2, 2014. Jacqueline Leung, a graduate student in the Cellular, Molecular and Biosciences (CMB) Program at the University of Vermont won for her publication, "Identification of T. gondii Myosin Light Chain-1 as a Direct Target of TachypleginA-2, a Small-Molecule Inhibitor of Parasite Motility and Invasion."1
› Verified 6 days ago
| Entity Name | South Metropolitan Anesthesia Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649265737 PECOS PAC ID: 1153370911 Enrollment ID: O20050119000369 |
News Archive
Governors nationwide are taking a scalpel to Medicaid, the jointly run state and federal health-care program for 48 million poor Americans, half of whom are children. The single biggest expense for states, Medicaid consumes about 22 percent of their total $1.6 trillion in expenditures, more than what is allocated to elementary and secondary education, according to a National Governors Association report.
An international team of researchers from the United States and Australia, including researchers at Moffitt Cancer Center in Tampa, Fla., have found that the oral BRAF inhibitor vemurafenib (PLX4032) when tested in a phase II clinical trial offered a high rate of response in patients with previously treated metastatic melanoma and who had the BRAF mutation.
Results from the first multi-center pilot study of deep brain stimulation (DBS) for major depressive disorder were published online today by the Journal of Neurosurgery. The study, conducted at three research facilities in Canada, was designed to replicate and build upon an earlier study by Dr. Andres Lozano and Dr. Helen Mayberg which was published in the journal Neuron in 2005.
Dr. Chris Berger, CMB Interim Director and Director of Graduate Education for the College of Medicine, announced the winner of the 2014 Norman R. Alpert Award at the annual Graduate Research Day for the CMB Program event held October 2, 2014. Jacqueline Leung, a graduate student in the Cellular, Molecular and Biosciences (CMB) Program at the University of Vermont won for her publication, "Identification of T. gondii Myosin Light Chain-1 as a Direct Target of TachypleginA-2, a Small-Molecule Inhibitor of Parasite Motility and Invasion."1
› Verified 6 days ago
| Entity Name | University Anesthesia Providers Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699711143 PECOS PAC ID: 7315986064 Enrollment ID: O20050502000881 |
News Archive
Governors nationwide are taking a scalpel to Medicaid, the jointly run state and federal health-care program for 48 million poor Americans, half of whom are children. The single biggest expense for states, Medicaid consumes about 22 percent of their total $1.6 trillion in expenditures, more than what is allocated to elementary and secondary education, according to a National Governors Association report.
An international team of researchers from the United States and Australia, including researchers at Moffitt Cancer Center in Tampa, Fla., have found that the oral BRAF inhibitor vemurafenib (PLX4032) when tested in a phase II clinical trial offered a high rate of response in patients with previously treated metastatic melanoma and who had the BRAF mutation.
Results from the first multi-center pilot study of deep brain stimulation (DBS) for major depressive disorder were published online today by the Journal of Neurosurgery. The study, conducted at three research facilities in Canada, was designed to replicate and build upon an earlier study by Dr. Andres Lozano and Dr. Helen Mayberg which was published in the journal Neuron in 2005.
Dr. Chris Berger, CMB Interim Director and Director of Graduate Education for the College of Medicine, announced the winner of the 2014 Norman R. Alpert Award at the annual Graduate Research Day for the CMB Program event held October 2, 2014. Jacqueline Leung, a graduate student in the Cellular, Molecular and Biosciences (CMB) Program at the University of Vermont won for her publication, "Identification of T. gondii Myosin Light Chain-1 as a Direct Target of TachypleginA-2, a Small-Molecule Inhibitor of Parasite Motility and Invasion."1
› Verified 6 days ago
| Entity Name | Twin Cities Anesthesia Solutions |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548898679 PECOS PAC ID: 1658701420 Enrollment ID: O20200417002396 |
News Archive
Governors nationwide are taking a scalpel to Medicaid, the jointly run state and federal health-care program for 48 million poor Americans, half of whom are children. The single biggest expense for states, Medicaid consumes about 22 percent of their total $1.6 trillion in expenditures, more than what is allocated to elementary and secondary education, according to a National Governors Association report.
An international team of researchers from the United States and Australia, including researchers at Moffitt Cancer Center in Tampa, Fla., have found that the oral BRAF inhibitor vemurafenib (PLX4032) when tested in a phase II clinical trial offered a high rate of response in patients with previously treated metastatic melanoma and who had the BRAF mutation.
Results from the first multi-center pilot study of deep brain stimulation (DBS) for major depressive disorder were published online today by the Journal of Neurosurgery. The study, conducted at three research facilities in Canada, was designed to replicate and build upon an earlier study by Dr. Andres Lozano and Dr. Helen Mayberg which was published in the journal Neuron in 2005.
Dr. Chris Berger, CMB Interim Director and Director of Graduate Education for the College of Medicine, announced the winner of the 2014 Norman R. Alpert Award at the annual Graduate Research Day for the CMB Program event held October 2, 2014. Jacqueline Leung, a graduate student in the Cellular, Molecular and Biosciences (CMB) Program at the University of Vermont won for her publication, "Identification of T. gondii Myosin Light Chain-1 as a Direct Target of TachypleginA-2, a Small-Molecule Inhibitor of Parasite Motility and Invasion."1
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Andrea Berube, 2651 Oak Lawn Dr, Northfield, MN 55057-3443 Ph: (612) 616-7731 | Andrea Berube, 1000 4th St Sw, Mason City, IA 50401-2800 Ph: (641) 428-7000 |
News Archive
Governors nationwide are taking a scalpel to Medicaid, the jointly run state and federal health-care program for 48 million poor Americans, half of whom are children. The single biggest expense for states, Medicaid consumes about 22 percent of their total $1.6 trillion in expenditures, more than what is allocated to elementary and secondary education, according to a National Governors Association report.
An international team of researchers from the United States and Australia, including researchers at Moffitt Cancer Center in Tampa, Fla., have found that the oral BRAF inhibitor vemurafenib (PLX4032) when tested in a phase II clinical trial offered a high rate of response in patients with previously treated metastatic melanoma and who had the BRAF mutation.
Results from the first multi-center pilot study of deep brain stimulation (DBS) for major depressive disorder were published online today by the Journal of Neurosurgery. The study, conducted at three research facilities in Canada, was designed to replicate and build upon an earlier study by Dr. Andres Lozano and Dr. Helen Mayberg which was published in the journal Neuron in 2005.
Dr. Chris Berger, CMB Interim Director and Director of Graduate Education for the College of Medicine, announced the winner of the 2014 Norman R. Alpert Award at the annual Graduate Research Day for the CMB Program event held October 2, 2014. Jacqueline Leung, a graduate student in the Cellular, Molecular and Biosciences (CMB) Program at the University of Vermont won for her publication, "Identification of T. gondii Myosin Light Chain-1 as a Direct Target of TachypleginA-2, a Small-Molecule Inhibitor of Parasite Motility and Invasion."1
› Verified 6 days ago
Carrie Potter, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 910 N Eisenhower Ave, Mason City, IA 50401 Phone: 641-428-7000 | |
Victoria Lee Stromer, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1631 4th St Sw, Mason City, IA 50401 Phone: 641-428-6000 Fax: 641-428-6007 | |
Ashley Matern, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1000 4th St Sw, Mason City, IA 50401 Phone: 641-428-6999 Fax: 641-428-6678 | |
Trisha Lynn Tibbitts, ARNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1631 4th St Sw # 114b, Mason City, IA 50401 Phone: 641-243-4593 | |
Alex Scott Farrell, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1000 4th St Sw, Mason City, IA 50401 Phone: 641-428-7234 Fax: 641-428-6373 | |
Tara Eisenlohr, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 100 1st St Nw Ste 200, Mason City, IA 50401 Phone: 641-423-5044 Fax: 641-423-0994 | |
Brooke Stewart, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1631 4th St Sw, Suite 114b, Mason City, IA 50401 Phone: 641-428-6000 Fax: 641-428-6007 |